Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%
Report ID | 41540 |
Drug Identification Number | 02141019 |
Brand name | CALCIUM GLUCONATE INJECTION, USP 10% |
Common or Proper name | Calcium Gluconate Injection USP 10% 100 mg/mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | CALCIUM GLUCONATE CALCIUM SACCHARATE |
Strength(s) | 94MG 4.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 mL Vial |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-03-14 |
Actual start date | |
Estimated end date | 2018-04-04 |
Actual end date | 2018-04-09 |
Shortage status | Resolved |
Updated date | 2018-04-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-04-10 | English | Compare |
v5 | 2018-04-09 | French | Compare |
v4 | 2018-04-09 | English | Compare |
v3 | 2018-03-15 | English | Compare |
v2 | 2018-03-02 | French | Compare |
v1 | 2018-03-02 | English | Compare |
Showing 1 to 6 of 6